Innovative CA Tumor Marker Tests Technologies and Emerging Markets

  • November 2012
  • -
  • Venture Planning Group
  • -
  • 278 pages

This report contains 278 pages, 40 tables and presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 278 pages and 40 tables

Table Of Contents

Table of Contents

I. Introduction
II. CA TUMOR MARKERS Worldwide Market and Technology Overview
A. CA Tumor Markers: Clinical Significance
and Laboratory Practices
1. CA 15-3/27.29
2. CA 19-9
3. CA 125
B. Instrumentation Review And
Market Needs
1. Abbott AxSYM
2. Abbott Architect c4000
3. Abbott Architect i2000 Series
4. Abbott Architect ci8200 System
5. Beckman Coulter UniCel Series
6. Beckman Coulter Access
7. Binding Site ESP600
8. bioMerieux Mini Vidas
9. Carolina Chemistries BioLis 24i
10. DiaSorin Liaison
11. Horiba ABX Pentra 400
12. Inverness DS2
13. JandJ Vitros ECi/ECiQ
14. JandJ Vitros 3600
15. JandJ Vitros 5600
16. Olympus AU5400
17. Olympus AU3000i
18. Olympus AU2700
19. Roche Modular Analytics
20. Roche Cobas Integra 400
21. Roche Cobas Integra 400 Plus
22. Roche Elecsys
23. Roche Cobas c311
24. Siemens ADVIA Centaur
25. Siemens Dimension
26. Siemens Dimension RxL Max
27. Siemens Dimension Vista 500
28. Siemens Immulite
29. Siemens Stratus
30. Tosoh AIA-Series
31. Vital Diagnostics ATAC 8000
32. Vital Diagnostics Envoy 500
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
E. Personal Testing
III. France: Market Size, Growth and Major Suppliers’
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers’
Sales and Market Shares
V. Italy: Test Volume and Diagnostics Sales Forecast
by Market Segment
VI. Japan: Market Size, Growth and Major Suppliers’
Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers’
Sales and Market Shares
VIII. U.K.: Test Volume and Diagnostics Sales Forecast
by Market Segment
IX. U.S.A.: Market Size, Growth and Major Suppliers’
Sales and Market Shares
XI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. Competitive Profiles
- Abbott
- AdnaGen
- Applied Gene Technologies
- Arca
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- Cepheid
- Correlogic Systems
- Decode
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Gen-Probe
- Guided Therapeutics
- Hologic
- Ipsogen
- Kreatech
- Kyowa Medex
- Life Technologies
- Mackay Life Sciences
- Myriad Genetics
- Nanogen Elitech
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics and Therapeutics
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

List of Tables
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
France
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
France
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
France
CA 125 Test Volume and Diagnostics Sales
by Market Segment
France
CA 15-3/27.29 Testing Market by Major Supplier
France
CA 19-9 Testing Market by Major Supplier
France
CA 125 Testing Market by Major Supplier
Germany
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Germany
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Germany
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Germany
CA 15-3/27.29 Testing Market by Major Supplier
Germany
CA 19-9 Testing Market by Major Supplier
Germany
CA 125 Testing Market by Major Supplier
Italy
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Italy
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Italy
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 15-3/27.29 Testing Market by Major Supplier
Japan
CA 19-9 Testing Market by Major Supplier
Japan
CA 125 Testing Market by Major Supplier
Spain
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 15-3/27.29 Testing Market by Major Supplier
Spain
CA 19-9 Testing Market by Major Supplier
Spain
CA 125 Testing Market by Major Supplier
U.K.
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
U.K.
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
U.K.
CA 125 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 125 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 15-3/27.29 Testing Market by Major Supplier
U.S.A.
CA 19-9 Testing Market by Major Supplier
U.S.A.
CA 125 Testing Market by Major Supplier

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.